nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—BCHE—Triamcinolone—psoriatic arthritis	0.161	0.894	CbGbCtD
Procainamide—Hepatic enzyme increased—Auranofin—psoriatic arthritis	0.025	0.0323	CcSEcCtD
Procainamide—CYP2D6—Dexamethasone—psoriatic arthritis	0.0192	0.107	CbGbCtD
Procainamide—Lupus erythematosus—Triamcinolone—psoriatic arthritis	0.0186	0.0241	CcSEcCtD
Procainamide—Hypotensive—Dexamethasone—psoriatic arthritis	0.0172	0.0223	CcSEcCtD
Procainamide—Hypotensive—Betamethasone—psoriatic arthritis	0.0172	0.0223	CcSEcCtD
Procainamide—Eosinophilia—Auranofin—psoriatic arthritis	0.0147	0.019	CcSEcCtD
Procainamide—Neutropenia—Auranofin—psoriatic arthritis	0.0139	0.0179	CcSEcCtD
Procainamide—Systemic lupus erythematosus—Triamcinolone—psoriatic arthritis	0.0125	0.0162	CcSEcCtD
Procainamide—Agranulocytosis—Auranofin—psoriatic arthritis	0.0123	0.016	CcSEcCtD
Procainamide—Hepatomegaly—Prednisolone—psoriatic arthritis	0.0106	0.0138	CcSEcCtD
Procainamide—Pericarditis—Methotrexate—psoriatic arthritis	0.0106	0.0137	CcSEcCtD
Procainamide—Dysgeusia—Auranofin—psoriatic arthritis	0.0101	0.0131	CcSEcCtD
Procainamide—Hepatomegaly—Triamcinolone—psoriatic arthritis	0.00979	0.0127	CcSEcCtD
Procainamide—Hepatomegaly—Methylprednisolone—psoriatic arthritis	0.00977	0.0126	CcSEcCtD
Procainamide—Angioedema—Auranofin—psoriatic arthritis	0.00944	0.0122	CcSEcCtD
Procainamide—Hepatomegaly—Dexamethasone—psoriatic arthritis	0.00888	0.0115	CcSEcCtD
Procainamide—Hepatomegaly—Betamethasone—psoriatic arthritis	0.00888	0.0115	CcSEcCtD
Procainamide—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00825	0.0107	CcSEcCtD
Procainamide—Anorexia—Auranofin—psoriatic arthritis	0.00804	0.0104	CcSEcCtD
Procainamide—Hepatomegaly—Prednisone—psoriatic arthritis	0.00773	0.01	CcSEcCtD
Procainamide—Vasculitis—Prednisolone—psoriatic arthritis	0.00772	0.00999	CcSEcCtD
Procainamide—Decreased appetite—Auranofin—psoriatic arthritis	0.00733	0.00949	CcSEcCtD
Procainamide—Vasculitis—Triamcinolone—psoriatic arthritis	0.0071	0.00919	CcSEcCtD
Procainamide—Vasculitis—Methylprednisolone—psoriatic arthritis	0.00708	0.00917	CcSEcCtD
Procainamide—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00689	0.00892	CcSEcCtD
Procainamide—Urticaria—Auranofin—psoriatic arthritis	0.0067	0.00867	CcSEcCtD
Procainamide—Abdominal pain—Auranofin—psoriatic arthritis	0.00666	0.00863	CcSEcCtD
Procainamide—Vasculitis—Dexamethasone—psoriatic arthritis	0.00644	0.00834	CcSEcCtD
Procainamide—Vasculitis—Betamethasone—psoriatic arthritis	0.00644	0.00834	CcSEcCtD
Procainamide—Pleural effusion—Methotrexate—psoriatic arthritis	0.00597	0.00774	CcSEcCtD
Procainamide—Pruritus—Auranofin—psoriatic arthritis	0.00596	0.00772	CcSEcCtD
Procainamide—Diarrhoea—Auranofin—psoriatic arthritis	0.00577	0.00747	CcSEcCtD
Procainamide—Vasculitis—Prednisone—psoriatic arthritis	0.00561	0.00726	CcSEcCtD
Procainamide—Vomiting—Auranofin—psoriatic arthritis	0.00536	0.00694	CcSEcCtD
Procainamide—Cardiac arrest—Prednisolone—psoriatic arthritis	0.0052	0.00673	CcSEcCtD
Procainamide—Cardiac failure—Methylprednisolone—psoriatic arthritis	0.00514	0.00666	CcSEcCtD
Procainamide—Nausea—Auranofin—psoriatic arthritis	0.00501	0.00648	CcSEcCtD
Procainamide—Oliguria—Methotrexate—psoriatic arthritis	0.00496	0.00643	CcSEcCtD
Procainamide—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.0049	0.00634	CcSEcCtD
Procainamide—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.00484	0.00626	CcSEcCtD
Procainamide—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.00478	0.00619	CcSEcCtD
Procainamide—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.00477	0.00618	CcSEcCtD
Procainamide—Vasculitis—Methotrexate—psoriatic arthritis	0.00469	0.00607	CcSEcCtD
Procainamide—Cardiac failure—Dexamethasone—psoriatic arthritis	0.00468	0.00605	CcSEcCtD
Procainamide—Cardiac failure—Betamethasone—psoriatic arthritis	0.00468	0.00605	CcSEcCtD
Procainamide—Lethargy—Betamethasone—psoriatic arthritis	0.00466	0.00603	CcSEcCtD
Procainamide—Lethargy—Dexamethasone—psoriatic arthritis	0.00466	0.00603	CcSEcCtD
Procainamide—Psychotic disorder—Betamethasone—psoriatic arthritis	0.00446	0.00577	CcSEcCtD
Procainamide—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.00446	0.00577	CcSEcCtD
Procainamide—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.00434	0.00562	CcSEcCtD
Procainamide—Cardiac arrest—Betamethasone—psoriatic arthritis	0.00434	0.00562	CcSEcCtD
Procainamide—DNMT1—Budesonide—Methylprednisolone—psoriatic arthritis	0.00413	0.0866	CbGdCrCtD
Procainamide—Cardiac failure—Prednisone—psoriatic arthritis	0.00407	0.00527	CcSEcCtD
Procainamide—DNMT1—Budesonide—Dexamethasone—psoriatic arthritis	0.00406	0.0853	CbGdCrCtD
Procainamide—DNMT1—Budesonide—Betamethasone—psoriatic arthritis	0.00406	0.0853	CbGdCrCtD
Procainamide—Lethargy—Prednisone—psoriatic arthritis	0.00406	0.00525	CcSEcCtD
Procainamide—DNMT1—Budesonide—Triamcinolone—psoriatic arthritis	0.00397	0.0833	CbGdCrCtD
Procainamide—Psychotic disorder—Prednisone—psoriatic arthritis	0.00388	0.00502	CcSEcCtD
Procainamide—Bradycardia—Prednisolone—psoriatic arthritis	0.00385	0.00499	CcSEcCtD
Procainamide—Cardiac arrest—Prednisone—psoriatic arthritis	0.00378	0.00489	CcSEcCtD
Procainamide—DNMT1—Budesonide—Prednisone—psoriatic arthritis	0.00377	0.0791	CbGdCrCtD
Procainamide—Hepatic failure—Methotrexate—psoriatic arthritis	0.0037	0.00478	CcSEcCtD
Procainamide—DNMT1—Budesonide—Prednisolone—psoriatic arthritis	0.00368	0.0772	CbGdCrCtD
Procainamide—Bradycardia—Triamcinolone—psoriatic arthritis	0.00354	0.00459	CcSEcCtD
Procainamide—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00353	0.00458	CcSEcCtD
Procainamide—Hallucination—Methylprednisolone—psoriatic arthritis	0.00345	0.00447	CcSEcCtD
Procainamide—Lethargy—Methotrexate—psoriatic arthritis	0.00339	0.00439	CcSEcCtD
Procainamide—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00322	0.00417	CcSEcCtD
Procainamide—Bradycardia—Dexamethasone—psoriatic arthritis	0.00321	0.00416	CcSEcCtD
Procainamide—Bradycardia—Betamethasone—psoriatic arthritis	0.00321	0.00416	CcSEcCtD
Procainamide—Neutropenia—Prednisone—psoriatic arthritis	0.00321	0.00416	CcSEcCtD
Procainamide—Hallucination—Dexamethasone—psoriatic arthritis	0.00314	0.00407	CcSEcCtD
Procainamide—Hallucination—Betamethasone—psoriatic arthritis	0.00314	0.00407	CcSEcCtD
Procainamide—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.00306	0.00396	CcSEcCtD
Procainamide—Depression—Prednisone—psoriatic arthritis	0.00305	0.00395	CcSEcCtD
Procainamide—Angioedema—Prednisolone—psoriatic arthritis	0.00301	0.0039	CcSEcCtD
Procainamide—Malaise—Prednisolone—psoriatic arthritis	0.00297	0.00385	CcSEcCtD
Procainamide—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00297	0.00384	CcSEcCtD
Procainamide—Convulsion—Prednisolone—psoriatic arthritis	0.00285	0.00369	CcSEcCtD
Procainamide—Eosinophilia—Methotrexate—psoriatic arthritis	0.00284	0.00368	CcSEcCtD
Procainamide—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00281	0.00364	CcSEcCtD
Procainamide—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.0028	0.00363	CcSEcCtD
Procainamide—Bradycardia—Prednisone—psoriatic arthritis	0.0028	0.00362	CcSEcCtD
Procainamide—Discomfort—Prednisolone—psoriatic arthritis	0.00277	0.00359	CcSEcCtD
Procainamide—Angioedema—Triamcinolone—psoriatic arthritis	0.00277	0.00358	CcSEcCtD
Procainamide—Angioedema—Methylprednisolone—psoriatic arthritis	0.00276	0.00357	CcSEcCtD
Procainamide—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00275	0.00356	CcSEcCtD
Procainamide—Hallucination—Prednisone—psoriatic arthritis	0.00274	0.00354	CcSEcCtD
Procainamide—Malaise—Triamcinolone—psoriatic arthritis	0.00273	0.00354	CcSEcCtD
Procainamide—Malaise—Methylprednisolone—psoriatic arthritis	0.00273	0.00353	CcSEcCtD
Procainamide—Neutropenia—Methotrexate—psoriatic arthritis	0.00268	0.00348	CcSEcCtD
Procainamide—Shock—Prednisolone—psoriatic arthritis	0.00264	0.00342	CcSEcCtD
Procainamide—Convulsion—Triamcinolone—psoriatic arthritis	0.00262	0.0034	CcSEcCtD
Procainamide—Convulsion—Methylprednisolone—psoriatic arthritis	0.00262	0.00339	CcSEcCtD
Procainamide—Myalgia—Triamcinolone—psoriatic arthritis	0.00258	0.00334	CcSEcCtD
Procainamide—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00257	0.00333	CcSEcCtD
Procainamide—Myalgia—Methylprednisolone—psoriatic arthritis	0.00257	0.00333	CcSEcCtD
Procainamide—Depression—Methotrexate—psoriatic arthritis	0.00255	0.0033	CcSEcCtD
Procainamide—Flushing—Prednisone—psoriatic arthritis	0.00255	0.0033	CcSEcCtD
Procainamide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00255	0.0033	CcSEcCtD
Procainamide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00255	0.0033	CcSEcCtD
Procainamide—Discomfort—Triamcinolone—psoriatic arthritis	0.00255	0.0033	CcSEcCtD
Procainamide—Discomfort—Methylprednisolone—psoriatic arthritis	0.00254	0.00329	CcSEcCtD
Procainamide—DNMT1—Betamethasone—Methylprednisolone—psoriatic arthritis	0.00252	0.053	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.00252	0.053	CbGdCrCtD
Procainamide—Renal failure—Methotrexate—psoriatic arthritis	0.00252	0.00326	CcSEcCtD
Procainamide—Angioedema—Dexamethasone—psoriatic arthritis	0.00251	0.00325	CcSEcCtD
Procainamide—Angioedema—Betamethasone—psoriatic arthritis	0.00251	0.00325	CcSEcCtD
Procainamide—Confusional state—Methylprednisolone—psoriatic arthritis	0.00249	0.00322	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Betamethasone—psoriatic arthritis	0.00248	0.0522	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Dexamethasone—psoriatic arthritis	0.00248	0.0522	CbGdCrCtD
Procainamide—Malaise—Dexamethasone—psoriatic arthritis	0.00248	0.00321	CcSEcCtD
Procainamide—Malaise—Betamethasone—psoriatic arthritis	0.00248	0.00321	CcSEcCtD
Procainamide—Shock—Triamcinolone—psoriatic arthritis	0.00243	0.00315	CcSEcCtD
Procainamide—DNMT1—Betamethasone—Triamcinolone—psoriatic arthritis	0.00243	0.051	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Triamcinolone—psoriatic arthritis	0.00243	0.051	CbGdCrCtD
Procainamide—Shock—Methylprednisolone—psoriatic arthritis	0.00243	0.00314	CcSEcCtD
Procainamide—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00239	0.00309	CcSEcCtD
Procainamide—Convulsion—Dexamethasone—psoriatic arthritis	0.00238	0.00308	CcSEcCtD
Procainamide—Convulsion—Betamethasone—psoriatic arthritis	0.00238	0.00308	CcSEcCtD
Procainamide—Myalgia—Dexamethasone—psoriatic arthritis	0.00234	0.00303	CcSEcCtD
Procainamide—Myalgia—Betamethasone—psoriatic arthritis	0.00234	0.00303	CcSEcCtD
Procainamide—Discomfort—Dexamethasone—psoriatic arthritis	0.00231	0.00299	CcSEcCtD
Procainamide—Discomfort—Betamethasone—psoriatic arthritis	0.00231	0.00299	CcSEcCtD
Procainamide—Hypotension—Methylprednisolone—psoriatic arthritis	0.0023	0.00298	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Prednisone—psoriatic arthritis	0.0023	0.0484	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Prednisone—psoriatic arthritis	0.0023	0.0484	CbGdCrCtD
Procainamide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00225	0.00292	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Prednisolone—psoriatic arthritis	0.00225	0.0472	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Prednisolone—psoriatic arthritis	0.00225	0.0472	CbGdCrCtD
Procainamide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00225	0.00291	CcSEcCtD
Procainamide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00222	0.00287	CcSEcCtD
Procainamide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00222	0.00287	CcSEcCtD
Procainamide—Shock—Betamethasone—psoriatic arthritis	0.00221	0.00286	CcSEcCtD
Procainamide—Shock—Dexamethasone—psoriatic arthritis	0.00221	0.00286	CcSEcCtD
Procainamide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.0022	0.00284	CcSEcCtD
Procainamide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.0022	0.00284	CcSEcCtD
Procainamide—Angioedema—Prednisone—psoriatic arthritis	0.00219	0.00283	CcSEcCtD
Procainamide—Malaise—Prednisone—psoriatic arthritis	0.00216	0.00279	CcSEcCtD
Procainamide—Anorexia—Dexamethasone—psoriatic arthritis	0.00214	0.00277	CcSEcCtD
Procainamide—Anorexia—Betamethasone—psoriatic arthritis	0.00214	0.00277	CcSEcCtD
Procainamide—Urticaria—Prednisolone—psoriatic arthritis	0.00214	0.00276	CcSEcCtD
Procainamide—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00213	0.00276	CcSEcCtD
Procainamide—Hypotension—Dexamethasone—psoriatic arthritis	0.0021	0.00271	CcSEcCtD
Procainamide—Hypotension—Betamethasone—psoriatic arthritis	0.0021	0.00271	CcSEcCtD
Procainamide—Convulsion—Prednisone—psoriatic arthritis	0.00207	0.00268	CcSEcCtD
Procainamide—Chills—Methotrexate—psoriatic arthritis	0.00206	0.00267	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00204	0.00265	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00204	0.00265	CcSEcCtD
Procainamide—Arthralgia—Prednisone—psoriatic arthritis	0.00204	0.00264	CcSEcCtD
Procainamide—Myalgia—Prednisone—psoriatic arthritis	0.00204	0.00264	CcSEcCtD
Procainamide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00204	0.00264	CcSEcCtD
Procainamide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00203	0.00263	CcSEcCtD
Procainamide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00202	0.00261	CcSEcCtD
Procainamide—Discomfort—Prednisone—psoriatic arthritis	0.00201	0.00261	CcSEcCtD
Procainamide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00198	0.00256	CcSEcCtD
Procainamide—Urticaria—Triamcinolone—psoriatic arthritis	0.00196	0.00254	CcSEcCtD
Procainamide—Urticaria—Methylprednisolone—psoriatic arthritis	0.00196	0.00254	CcSEcCtD
Procainamide—Dysgeusia—Methotrexate—psoriatic arthritis	0.00196	0.00254	CcSEcCtD
Procainamide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00195	0.00253	CcSEcCtD
Procainamide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00195	0.00252	CcSEcCtD
Procainamide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00195	0.00252	CcSEcCtD
Procainamide—Decreased appetite—Betamethasone—psoriatic arthritis	0.00195	0.00252	CcSEcCtD
Procainamide—Shock—Prednisone—psoriatic arthritis	0.00192	0.00249	CcSEcCtD
Procainamide—Anorexia—Prednisone—psoriatic arthritis	0.00186	0.00241	CcSEcCtD
Procainamide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.00186	0.0024	CcSEcCtD
Procainamide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00185	0.00239	CcSEcCtD
Procainamide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00185	0.00239	CcSEcCtD
Procainamide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00183	0.00237	CcSEcCtD
Procainamide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00183	0.00237	CcSEcCtD
Procainamide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00182	0.00236	CcSEcCtD
Procainamide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00182	0.00235	CcSEcCtD
Procainamide—Malaise—Methotrexate—psoriatic arthritis	0.0018	0.00234	CcSEcCtD
Procainamide—Urticaria—Betamethasone—psoriatic arthritis	0.00178	0.00231	CcSEcCtD
Procainamide—Urticaria—Dexamethasone—psoriatic arthritis	0.00178	0.00231	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00178	0.0023	CcSEcCtD
Procainamide—Dizziness—Prednisolone—psoriatic arthritis	0.00178	0.0023	CcSEcCtD
Procainamide—Asthenia—Triamcinolone—psoriatic arthritis	0.00177	0.0023	CcSEcCtD
Procainamide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00177	0.0023	CcSEcCtD
Procainamide—Abdominal pain—Betamethasone—psoriatic arthritis	0.00177	0.0023	CcSEcCtD
Procainamide—Body temperature increased—Betamethasone—psoriatic arthritis	0.00177	0.0023	CcSEcCtD
Procainamide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00177	0.0023	CcSEcCtD
Procainamide—Asthenia—Methylprednisolone—psoriatic arthritis	0.00177	0.00229	CcSEcCtD
Procainamide—Pruritus—Triamcinolone—psoriatic arthritis	0.00175	0.00226	CcSEcCtD
Procainamide—Pruritus—Methylprednisolone—psoriatic arthritis	0.00174	0.00226	CcSEcCtD
Procainamide—Convulsion—Methotrexate—psoriatic arthritis	0.00173	0.00224	CcSEcCtD
Procainamide—Arthralgia—Methotrexate—psoriatic arthritis	0.0017	0.0022	CcSEcCtD
Procainamide—Myalgia—Methotrexate—psoriatic arthritis	0.0017	0.0022	CcSEcCtD
Procainamide—Decreased appetite—Prednisone—psoriatic arthritis	0.0017	0.0022	CcSEcCtD
Procainamide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00169	0.00218	CcSEcCtD
Procainamide—Discomfort—Methotrexate—psoriatic arthritis	0.00168	0.00218	CcSEcCtD
Procainamide—Confusional state—Methotrexate—psoriatic arthritis	0.00165	0.00213	CcSEcCtD
Procainamide—Dizziness—Triamcinolone—psoriatic arthritis	0.00163	0.00212	CcSEcCtD
Procainamide—Dizziness—Methylprednisolone—psoriatic arthritis	0.00163	0.00211	CcSEcCtD
Procainamide—Feeling abnormal—Prednisone—psoriatic arthritis	0.00161	0.00208	CcSEcCtD
Procainamide—Asthenia—Dexamethasone—psoriatic arthritis	0.00161	0.00208	CcSEcCtD
Procainamide—Asthenia—Betamethasone—psoriatic arthritis	0.00161	0.00208	CcSEcCtD
Procainamide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.0016	0.00207	CcSEcCtD
Procainamide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.0016	0.00207	CcSEcCtD
Procainamide—Nausea—Prednisolone—psoriatic arthritis	0.0016	0.00207	CcSEcCtD
Procainamide—Pruritus—Dexamethasone—psoriatic arthritis	0.00159	0.00205	CcSEcCtD
Procainamide—Pruritus—Betamethasone—psoriatic arthritis	0.00159	0.00205	CcSEcCtD
Procainamide—Vomiting—Triamcinolone—psoriatic arthritis	0.00157	0.00203	CcSEcCtD
Procainamide—Vomiting—Methylprednisolone—psoriatic arthritis	0.00157	0.00203	CcSEcCtD
Procainamide—Anorexia—Methotrexate—psoriatic arthritis	0.00156	0.00201	CcSEcCtD
Procainamide—Urticaria—Prednisone—psoriatic arthritis	0.00155	0.00201	CcSEcCtD
Procainamide—Abdominal pain—Prednisone—psoriatic arthritis	0.00154	0.002	CcSEcCtD
Procainamide—Body temperature increased—Prednisone—psoriatic arthritis	0.00154	0.002	CcSEcCtD
Procainamide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00153	0.00199	CcSEcCtD
Procainamide—Diarrhoea—Betamethasone—psoriatic arthritis	0.00153	0.00199	CcSEcCtD
Procainamide—Hypotension—Methotrexate—psoriatic arthritis	0.00153	0.00197	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00149	0.00193	CcSEcCtD
Procainamide—Dizziness—Dexamethasone—psoriatic arthritis	0.00148	0.00192	CcSEcCtD
Procainamide—Dizziness—Betamethasone—psoriatic arthritis	0.00148	0.00192	CcSEcCtD
Procainamide—Nausea—Triamcinolone—psoriatic arthritis	0.00147	0.0019	CcSEcCtD
Procainamide—Nausea—Methylprednisolone—psoriatic arthritis	0.00147	0.0019	CcSEcCtD
Procainamide—Hypersensitivity—Prednisone—psoriatic arthritis	0.00144	0.00186	CcSEcCtD
Procainamide—Vomiting—Betamethasone—psoriatic arthritis	0.00143	0.00185	CcSEcCtD
Procainamide—Vomiting—Dexamethasone—psoriatic arthritis	0.00143	0.00185	CcSEcCtD
Procainamide—Decreased appetite—Methotrexate—psoriatic arthritis	0.00142	0.00184	CcSEcCtD
Procainamide—Asthenia—Prednisone—psoriatic arthritis	0.0014	0.00181	CcSEcCtD
Procainamide—Pruritus—Prednisone—psoriatic arthritis	0.00138	0.00179	CcSEcCtD
Procainamide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00135	0.00174	CcSEcCtD
Procainamide—Diarrhoea—Prednisone—psoriatic arthritis	0.00134	0.00173	CcSEcCtD
Procainamide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00133	0.00173	CcSEcCtD
Procainamide—Nausea—Dexamethasone—psoriatic arthritis	0.00133	0.00172	CcSEcCtD
Procainamide—Nausea—Betamethasone—psoriatic arthritis	0.00133	0.00172	CcSEcCtD
Procainamide—Urticaria—Methotrexate—psoriatic arthritis	0.0013	0.00168	CcSEcCtD
Procainamide—Dizziness—Prednisone—psoriatic arthritis	0.00129	0.00167	CcSEcCtD
Procainamide—Body temperature increased—Methotrexate—psoriatic arthritis	0.00129	0.00167	CcSEcCtD
Procainamide—Abdominal pain—Methotrexate—psoriatic arthritis	0.00129	0.00167	CcSEcCtD
Procainamide—Vomiting—Prednisone—psoriatic arthritis	0.00124	0.00161	CcSEcCtD
Procainamide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.0012	0.00156	CcSEcCtD
Procainamide—Asthenia—Methotrexate—psoriatic arthritis	0.00117	0.00152	CcSEcCtD
Procainamide—Nausea—Prednisone—psoriatic arthritis	0.00116	0.0015	CcSEcCtD
Procainamide—Pruritus—Methotrexate—psoriatic arthritis	0.00115	0.0015	CcSEcCtD
Procainamide—Diarrhoea—Methotrexate—psoriatic arthritis	0.00112	0.00145	CcSEcCtD
Procainamide—Dizziness—Methotrexate—psoriatic arthritis	0.00108	0.0014	CcSEcCtD
Procainamide—Vomiting—Methotrexate—psoriatic arthritis	0.00104	0.00134	CcSEcCtD
Procainamide—Nausea—Methotrexate—psoriatic arthritis	0.00097	0.00126	CcSEcCtD
